• Professor Kim is an academic ‘surgeon-scientist’, and after comprehensive research training at Harvard University and Birmingham University he was awarded a PhD doctorate and the prestigious 'Syme Medal' by the Royal College of Surgeons).
• He continues to undertake an active research program in thyroid cancer/surgery. This includes studies into the role of immunotherapy in aggressive thyroid cancers, circulating DNA as a novel biomarker (so called ‘liquid biopsy’), qualitative research in surgical outcomes and patient experience.
• Supervises several MD/PhD research fellows as part of a wider research program at the Institute of Cancer Research, working closely with Dr Kate Newbold and Professor Kevin Harrington.
• Has been awarded more than £2.5 Million in research funds, and furthermore, he recently was successful in being awarded a major NIHR HTA grant for a multi-centre clinical trial in thyroid cancer (Chief Investigator - HoT Trial).
• Contributes to several international textbooks in head & neck and thyroid surgery. He is an invited faculty member in several international training courses and surgical societies including the World Thyroid Congress, International Robotic Surgery Symposium and the Asia-Pacific Society Thyroid Surgery.
• Currently a committee member of National Institute of Cancer Research (Thyroid group) which guides the research program in the UK and advises the National Institute of Clinical Excellence in minimally-invasive thyroid surgery.